Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection.

PLoS One · 2025 · PMC11798459 · PMID 39908288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

However, in addition to RANTES/CCL5, there was an overall trend toward reduced transcript levels in the OB-002 group compared to both the vehicle controls, and with respect to mock animals.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.